{"id":9683,"date":"2026-07-31T20:06:04","date_gmt":"2026-07-31T20:06:04","guid":{"rendered":"https:\/\/godshand.link\/ground_post\/who-position-paper-on-covid-19-vaccines-july-2026\/"},"modified":"2026-07-31T20:06:04","modified_gmt":"2026-07-31T20:06:04","slug":"who-position-paper-on-covid-19-vaccines-july-2026","status":"publish","type":"ground_post","link":"http:\/\/godshand.link\/en_gb\/ground_post\/who-position-paper-on-covid-19-vaccines-july-2026\/","title":{"rendered":"WHO position paper on COVID-19 vaccines &#8211; July 2026"},"content":{"rendered":"<p><br \/>\n<\/p>\n<section class=\"dynamic-content__section dynamic-content__container\">\n<div class=\"dynamic-content__section-container\">\n<div class=\"dynamic-content__figure-container\">\n<figure class=\"dynamic-content__figure\">\n      <img decoding=\"async\" src=\"https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/5dcd6536-4447-44ba-a945-a2c787344f4e\/content\" alt=\"WHO position paper on COVID-19 vaccines - July 2026\"><br \/>\n     <\/figure>\n<div class=\"button button-blue-background\"><a target=\"_blank\" href=\"https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/abc7e160-6cd7-4762-a492-40293d4fa7b1\/content\" onclick=\"sendGaEvent('Download','https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/abc7e160-6cd7-4762-a492-40293d4fa7b1\/content')\">Download <span>(253.5 kB)<\/span><\/a><\/div><\/div>\n<div class=\"dynamic-content__description-container\">\n<div class=\"row\">\n<div class=\"col-md-8\">\n<div class=\"dynamic-content__description\">\n<h3>Overview <\/h3>\n<p>This WHO Position Paper updates WHO recommendations on the use of COVID-19 vaccines in the context of sustained SARS-CoV-2 circulation, high levels of population immunity, and the availability of variant-adapted vaccines. <br \/>Developed following recommendations by the Strategic Advisory Group of Experts (SAGE) on Immunization, it summarizes current evidence on COVID-19 epidemiology, populations at increased risk of severe disease, vaccine characteristics, immunogenicity, effectiveness, safety, and programme implementation.<br \/>\n<br \/>The paper presents WHO\u2019s current policy recommendations for the use of COVID-19 vaccines across different population groups and settings, addressing vaccine schedules, product choice, coadministration, implementation considerations, and monitoring. <br \/>It also identifies evidence gaps and research priorities and provides guidance to support national immunization policies and vaccination programmes as countries integrate COVID-19 vaccination into long-term disease management strategies.<\/p>\n<\/p><\/div><\/div>\n<div class=\"col-md-4\">\n<div class=\"dynamic-content__details\">\n<div class=\"detail who-team\">\n<div class=\"label\">WHO Team<\/div>\n<div class=\"value\">\n                 <span><br \/>\nImmunization, Vaccines and Biologicals (IVB),                  <\/span><br \/>\n                 <span><br \/>\nStrategic Advisory Group of Experts on Immunization                 <\/span>\n         <\/div><\/div>\n<div class=\"detail\">\n<div class=\"label\">Editors<\/div>\n<div class=\"value\">World Health Organization<\/div><\/div>\n<div class=\"detail\">\n<div class=\"label\">Number of pages<\/div>\n<div class=\"value\">18<\/div><\/div>\n<div class=\"detail\">\n<div class=\"label\">Reference numbers<\/div>\n<div class=\"value\">\n<div><strong class=\"label-sm\">WHO Reference Number: <\/strong><span>WER No. 30, 2026, 101, 134-151<\/span><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>\n<\/section>\n<p><br \/>\n<br \/><a href=\"https:\/\/www.who.int\/publications\/i\/item\/who-wer101-30-138-156?rand=6398\" target=\"_blank\">Source link <\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Download (253.5 kB) Overview This WHO Position Paper updates WHO recommendations on the use of COVID-19 vaccines in the context of sustained SARS-CoV-2 circulation, high levels of population immunity, and the availability of variant-adapted vaccines. Developed following recommendations by the Strategic Advisory Group of Experts (SAGE) on Immunization, it summarizes current evidence on COVID-19 epidemiology, populations at increased risk of&hellip;<\/p>","protected":false},"author":99035,"featured_media":9684,"parent":0,"menu_order":0,"comment_status":"open","ping_status":"open","template":"","format":"standard","meta":{"give_campaign_id":0,"footnotes":""},"tags":[1197,807,1066,2736,2949],"ground_category":[315,316],"class_list":["post-9683","ground_post","type-ground_post","status-publish","format-standard","has-post-thumbnail","hentry","tag-covid19","tag-july","tag-paper","tag-position","tag-vaccines","ground_category-2-grounds-tribulation","ground_category-2-1-time-disease"],"fifu_image_url":"https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/5dcd6536-4447-44ba-a945-a2c787344f4e\/content","_links":{"self":[{"href":"http:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/ground_post\/9683","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/ground_post"}],"about":[{"href":"http:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/types\/ground_post"}],"author":[{"embeddable":true,"href":"http:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/users\/99035"}],"replies":[{"embeddable":true,"href":"http:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/comments?post=9683"}],"version-history":[{"count":0,"href":"http:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/ground_post\/9683\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/media\/9684"}],"wp:attachment":[{"href":"http:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/media?parent=9683"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/tags?post=9683"},{"taxonomy":"ground_category","embeddable":true,"href":"http:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/ground_category?post=9683"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}